Gene: FAM86B2
Official Full Name: family with sequence similarity 86 member B2provided by HGNC
Gene Summary: Predicted to enable protein-lysine N-methyltransferase activity. Predicted to be involved in regulation of translation. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17826 | FAM86B2 Knockout cell line (HeLa) | Human | FAM86B2 | 1:3~1:6 | Negative | Online Inquiry |
FAM86B2 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the FAM86B2 gene, which is implicated in various biological processes and disease mechanisms. Gene knockout techniques utilize targeted genomic editing—often employing CRISPR-Cas9 technology—to effectively disable the FAM86B2 gene. This results in a cell line that lacks the functional protein typically produced by this gene, allowing for in-depth analysis of its role in cellular functionality, signaling pathways, and potential involvement in pathologies such as cancer.
The primary function of these cell lines is to serve as research tools for dissecting the biological implications of FAM86B2 absence. Researchers utilize these models to identify how the loss of FAM86B2 affects cellular behavior, gene expression profiles, and responses to various stimuli. This phenotype elucidation can aid in understanding the gene's contribution to disease states, thus providing insights for therapeutic target identification.
Scientifically, the FAM86B2 Gene Knockout Cell Lines are invaluable in both basic and applied research contexts. They can be instrumental in unraveling the complexities of gene function and can be utilized in drug discovery and development efforts, as they allow researchers to observe the pharmacological effects of compounds on systems devoid of the targeted gene.
A significant advantage of our FAM86B2 Gene Knockout Cell Lines lies in their reliability and adaptability compared to traditional cell lines or models that might not accurately reflect the gene's functional loss. Our product offers superior consistency in the experimental environment and is available with comprehensive support and protocols, enhancing the ease of integration into various research frameworks.
Researchers, clinicians, and pharmaceutical developers will find tremendous value in these knockout cell lines, as they provide a robust platform for advancing knowledge and innovation in gene function and disease mechanisms. By choosing our FAM86B2 Gene Knockout Cell Lines, users invest in a high-quality, scientifically validated resource designed to empower their research objectives.
Our company specializes in the production of cutting-edge biological products, ensuring the highest standards of quality and reproducibility in our offerings, thus supporting the scientific community in its endeavor to advance human health through innovative research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.